View in EDS HTML Full Text PDF Full Text

Selective COX-2 inhibitors as anticancer agents: a patent review (2018-2023).

Saved in:
Bibliographic Details
Title: Selective COX-2 inhibitors as anticancer agents: a patent review (2018-2023).
Authors: Mahboubi-Rabbani M; Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran., Abdolghaffari AH; Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.; GI Pharmacology Interest Group (GPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran., Ghesmati M; Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran., Amini A; Department of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Zarghi A; Department of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Source: Expert opinion on therapeutic patents [Expert Opin Ther Pat] 2024 Sep; Vol. 34 (9), pp. 733-757. Date of Electronic Publication: 2024 Jul 03.
Publication Type: Journal Article; Review
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 9516419 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7674 (Electronic) Linking ISSN: 13543776 NLM ISO Abbreviation: Expert Opin Ther Pat Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38958471
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Selective COX-2 inhibitors as anticancer agents: a patent review (2018-2023).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mahboubi-Rabbani+M%22">Mahboubi-Rabbani M</searchLink>; Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Abdolghaffari+AH%22">Abdolghaffari AH</searchLink>; Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.; GI Pharmacology Interest Group (GPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Ghesmati+M%22">Ghesmati M</searchLink>; Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Amini+A%22">Amini A</searchLink>; Department of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Zarghi+A%22">Zarghi A</searchLink>; Department of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229516419%22">Expert opinion on therapeutic patents</searchLink> [Expert Opin Ther Pat] 2024 Sep; Vol. 34 (9), pp. 733-757. <i>Date of Electronic Publication: </i>2024 Jul 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Informa+Healthcare%22">Informa Healthcare </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9516419 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-7674 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213543776%22">13543776 </searchLink><i>NLM ISO Abbreviation: </i>Expert Opin Ther Pat <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38958471
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/13543776.2024.2373771
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 733
    Titles:
      – TitleFull: Selective COX-2 inhibitors as anticancer agents: a patent review (2018-2023).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mahboubi-Rabbani M
      – PersonEntity:
          Name:
            NameFull: Abdolghaffari AH
      – PersonEntity:
          Name:
            NameFull: Ghesmati M
      – PersonEntity:
          Name:
            NameFull: Amini A
      – PersonEntity:
          Name:
            NameFull: Zarghi A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2024 Sep
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1744-7674
          Numbering:
            – Type: volume
              Value: 34
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Expert opinion on therapeutic patents
              Type: main
ResultId 1